| Literature DB >> 34907321 |
Amaya Ayala-Garcia1,2,3, Laura Serra4,5,6,7, Julio C Hernando-Rodriguez4, Fernando G Benavides4,5,6.
Abstract
Cancer incidence and survival rates have increased in the last decades and as a result, the number of working age people diagnosed with cancer who return to work. In this study the probability of accumulating days of employment and employment participation trajectories (EPTs) in a sample of salaried workers in Catalonia (Spain) who had a sickness absence (SA) due to cancer were compared to salaried workers with SA due to other diagnoses or without SA. Each individual with SA due to cancer between 2012 and 2015 was matched by age, sex, and onset of time at risk to a worker with SA due to other diagnoses and another worker without SA. Accumulated days of employment were measured, and negative binomial models were applied to assess differences between comparison groups. Latent class models were applied to identify EPTs and multinomial regression models to analyse the probability of belonging to one EPT of each group. Men and women without SA or with SA due to other diagnoses had at least a 9% higher probability of continuing in employment compared to workers who had a SA due to cancer, especially among men without SA (adjusted IRR 1.27, 95% CI 1.06‒1.53). Men without SA had the highest probability of having high stable EPT compared to workers who had a SA due to cancer (adjusted RRR 3.21, 95% CI 1.87‒5.50). Even though workers with SA due to cancer continue working afterwards, they do it less often than matched controls and with a less stable employment trajectory. Health and social protection systems should guaranty cancer survivors the opportunity to continue voluntary participation in the labour market.Entities:
Mesh:
Year: 2021 PMID: 34907321 PMCID: PMC8671387 DOI: 10.1038/s41598-021-03368-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Employment-related characteristics among a sample of salaried workers with a SA due to cancer, SA due to other diagnoses, or no SA at all in Catalonia during the follow-up period (2012 and 2018), and previous employment 5 years prior to cohort entrance.
| Men (N = 675) | Women (N = 873) | |||||||
|---|---|---|---|---|---|---|---|---|
| SA cancer (N = 225) | SA other diagnoses (N = 225) | No SA any diagnoses (N = 225) | SA cancer (N = 291) | SA other diagnoses (N = 291) | No SA any diagnoses (N = 291) | |||
| Total accumulated days of employment | 262,869 | 286,245 | 328,939 | 393,825 | 425,556 | 434,249 | ||
SA, sickness absence; Follow-up period ranged from 3 to 7 years from entrance to the cohort until end of 2018; Previous 5 years refers to each individual´s entrance; SD, standard deviation. *p < 0.05, **p < 0.01, ***p < 0.001.
Probability of employment among salaried workers with a SA due to cancer (reference) and comparison groups adjusted individually by company characteristics and employment-related factors.
| Men | Women | |||||
|---|---|---|---|---|---|---|
| IRR | 95% CI | IRR | 95% CI | |||
| SA cancer | 1 | 1 | ||||
| SA other diagnoses | 1.09 | (0.90‒1.32) | 0.386 | 1.08 | (0.95‒1.23) | 0.234 |
| No SA any diagnoses | 1.25 | (1.03‒1.52) | 0.022* | 1.10 | (0.97‒1.25) | 0.134 |
| SA other diagnoses | 1.06 | (0.89‒1.28) | 0.503 | 1.08 | (0.95‒1.22) | 0.226 |
| No SA any diagnoses | 1.21 | (1.01‒1.46) | 0.037* | 1.09 | (0.96‒1.24) | 0.167 |
| SA other diagnoses | 1.06 | (0.88‒1.27) | 0.564 | 1.08 | (0.95‒1.22) | 0.233 |
| No SA any diagnoses | 1.22 | (1.02‒1.47) | 0.032* | 1.09 | (0.97‒1.24) | 0.161 |
| SA other diagnoses | 1.12 | (0.94‒1.35) | 0.203 | 1.07 | (0.95‒1.20) | 0.253 |
| No SA any diagnoses | 1.30 | (1.09‒1.56) | 0.004** | 1.11 | (0.99‒1.25) | 0.071 |
| SA other diagnoses | 1.05 | (0.87‒1.27) | 0.605 | 1.10 | (0.97‒1.26) | 0.134 |
| No SA any diagnoses | 1.20 | (0.99‒1.45) | 0.051 | 1.11 | (0.98‒1.27) | 0.101 |
| SA other diagnoses | 1.06 | (0.88‒1.28) | 0.533 | 1.07 | (0.94‒1.21) | 0.297 |
| No SA any diagnoses | 1.25 | (1.04‒1.50) | 0.020* | 1.09 | (0.96‒1.24) | 0.164 |
| SA other diagnoses | 1.05 | (0.88‒1.26) | 0.594 | 1.07 | (0.94‒1.21) | 0.307 |
| No SA any diagnoses | 1.23 | (1.02‒1.45) | 0.026* | 1.10 | (0.97‒1.25) | 0.141 |
| SA other diagnoses | 1.05 | (0.87‒1.27) | 0.585 | 1.11 | (0.97‒1.26) | 0.134 |
| No SA any diagnoses | 1.23 | (1.02‒1.48) | 0.034* | 1.09 | (0.95‒1.24) | 0.220 |
| SA other diagnoses | 1.11 | (0.91‒1.34) | 0.299 | 1.07 | (0.94‒1.21) | 0.317 |
| No SA any diagnoses | 1.26 | (1.04‒1.52) | 0.018* | 1.10 | (0.97‒1.24) | 0.155 |
| SA other diagnoses | 1.09 | (0.91‒1.30) | 0.376 | 1.10 | (0.97‒1.24) | 0.130 |
| No SA any diagnoses | 1.27 | (1.06‒1.53) | 0.009** | 1.09 | (0.97‒1.23) | 0.162 |
SA, sickness absence; IRR, incidence rate ratio; CI, confidence interval.
Figure 1Observed and expected trajectories considering number of days in employment per year in a sample of salaried men (top) and women (bottom) in Catalonia (2012–2018).
Employment-related characteristics measured in the follow-up period (2012 and 2018) and previous employment measured 5 years before cohort entrance among a sample of salaried workers living in Catalonia across employment participation trajectories (EPTs) (2012–2018).
| Employment Trajectories | ||||||||
|---|---|---|---|---|---|---|---|---|
| Men (N = 675) | Women (N = 873) | |||||||
| Low (28.1%) | Decreasing (11.6%) | High Stable (60.3%) | p value | Low Fluctuating (6.4%) | Middle Fluctuating (18.8%) | High Stable (74.8%) | ||
| N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | |||
| SA cancer | 82 (36.4) | 25 (11.1) | 118 (52.4) | 15 (5.2) | 71 (24.4) | 205 (70.5) | ||
| SA other diagnoses | 69 (30.7) | 23 (10.2) | 133 (59.1) | 20 (6.9) | 48 (16.5) | 223 (76.6) | ||
| No SA any diagnoses | 39 (17.3) | 30 (13.3) | 156 (69.3) | 21 (7.2) | 45 (15.5) | 225 (77.3) | ||
| ≤ 25 | * | 2 (2.6) | 4 (10.0) | < 0.0001*** | 1 (1.8) | 1 (0.6) | 7 (1.1) | < 0.0001*** |
| 26–35 | 10 (5.3) | 9 (11.5) | 53 (13.0) | 10 (17.9) | 15 (9.2) | 77 (11.8) | ||
| 36–45 | 19 (10.0) | 9 (11.5) | 92 (22.6) | 21 (37.5) | 29 (17.7) | 232 (35.5) | ||
| 46–55 | 43 (22.6) | 11 (14.1) | 174 (42.8) | 15 (26.8) | 38 (23.2) | 253 (38.8) | ||
| > 55 | 118 (62.1) | 47 (60.3) | 84 (20.6) | 9 (16.1) | 81 (49.4) | 84 (12.9) | ||
| Permanent | 135 (73.8) | 59 (75.6) | 366 (89.9) | < 0.0001*** | 40 (71.4) | 111 (68.5) | 568 (87.0) | < 0.0001*** |
| Temporary | 48 (26.2) | 19 (24.4) | 41 (10.1) | 16 (28.6) | 51 (31.5) | 85 (13.0) | ||
| Full-time (> 87.5%) | 146 (79.8) | 61 (78.2) | 362 (88.9) | 0.013* | 43 (76.8) | 101 (62.4) | 493 (75.5) | 0.003** |
| Part-time (50–87.5%) | 14 (7.7) | 4 (5.1) | 18 (4.4) | 10 (17.9) | 32 (19.8) | 110 (16.9) | ||
| Short and marginal part-time (≤ 37.5%-49%) | 23 (12.6) | 13 (16.7) | 27 (6.6) | 3 (5.4) | 29 (17.9) | 50 (7.65) | ||
| High (> 2370.0 €) | 57 (31.7) | 22 (28.2) | 207 (50.9) | < 0.0001*** | 9 (16.1) | 29 (18.8) | 185 (28.3) | < 0.0001*** |
| Medium (1451.0—2370.0 €) | 52 (28.9) | 25 (32.1) | 141 (34.6) | 16 (28.6) | 24 (15.6) | 251 (38.4) | ||
| Low (≤ 1450.0 €) | 71 (39.4) | 31 (39.7) | 59 (14.5) | 31 (55.4) | 101 (65.6) | 217 (33.2) | ||
| Non-manual skilled | 42 (23.0) | 14 (18.0) | 100 (24.6) | 0.199 | 4 (7.1) | 35 (21.6) | 176 (27.0) | 0.001** |
| Non-manual non-skilled | 59 (32.2) | 23 (29.5) | 130 (31.9) | 31 (55.4) | 60 (37.0) | 288 (44.1) | ||
| Manual skilled | 57 (31.2) | 28 (35.9) | 147 (36.1) | 13 (23.2) | 26 (16.1) | 91 (13.9) | ||
| Manual non-skilled | 18 (9.8) | 10 (12.8) | 22 (5.4) | 4 (7.1) | 32 (19.8) | 70 (10.7) | ||
| Agriculture, hunting, forestry, fishing, mining, and quarrying | 2 (1.1) | 2 (2.6) | 1 (0.3) | 0.001** | 1 (1.8) | 1 (0.6) | 1 (0.2) | 0.013* |
| Manufacturing, energy construction | 55 (29.0) | 29 (37.2) | 124 (30.5) | 6 (10.7) | 15 (9.2) | 92 (14.1) | ||
| Services | 119 (62.6) | 44 (56.4) | 277 (68.1) | 48 (85.7) | 139 (84.8) | 550 (84.2) | ||
| Small-medium (≤ 100 workers) | 133 (72.7) | 46 (59.0) | 238 (58.5) | 0.004** | 30 (53.6) | 102 (63.0) | 339 (51.9) | 0.041* |
| Big (> 100 workers) | 50 (27.3) | 32 (41.0) | 169 (41.5) | 26 (46.4) | 60 (37.0) | 314 (48.1) | ||
| Private | 135 (73.8) | 61 (78.2) | 319 (78.4) | 0.003** | 42 (75.0) | 118 (72.8) | 433 (66.3) | 0.006** |
| Public | 22 (12.0) | 11 (14.1) | 68 (16.7) | 6 (10.7) | 19 (11.7) | 149 (22.8) | ||
SA, sickness absence; Follow-up period ranged from 3 to 7 years, from entrance to the cohort until end of 2018; Previous 5 years was calculated from each individual´s entrance; SD, standard deviation. *p < 0.05, **p < 0.01, ***p < 0.001.
Probability of belonging to employment participation trajectories (EPTs) among salaried workers with a SA due to cancer (reference) and comparison groups.
| Men | Women | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Decreasing vs. Low | High Stable vs. Low | Middle Fluctuating vs. Low Fluctuating | High Stable vs. Low Fluctuating | |||||||||
| RRR | 95% CI | RRR | 95% CI | RRR | 95% CI | RRR | 95% CI | |||||
| SA cancer | 1 | 1 | 1 | 1 | ||||||||
| SA other diagnoses | 1.09 | (0.57‒2.10) | 0.788 | 1.34 | (0.89‒2.01) | 0.157 | 0.51 | (0.24‒1.09) | 0.081 | 0.82 | (0.41‒1.64) | 0.566 |
| No SA any diagnoses | 2.52 | (1.31‒4.85) | 0.006** | 2.78 | (1.77‒4.36) | < 0.0001*** | 0.45 | (0.21‒0.97) | 0.041* | 0.78 | (0.39‒1.56) | 0.489 |
| SA other diagnoses | 1.00 | (0.52‒1.92) | 0.997 | 1.21 | (0.80‒1.84) | 0.374 | 0.51 | (0.24‒1.11) | 0.089 | 0.86 | (0.43‒1.74) | 0.682 |
| No SA any diagnoses | 2.30 | (1.19‒4.44) | 0.013 | 2.50 | (1.56‒3.93) | < 0.0001*** | 0.46 | (0.22‒0.99) | 0.048* | 0.80 | (0.40‒1.60) | 0.527 |
| SA other diagnoses | 1.01 | (0.52‒1.94) | 0.976 | 1.21 | (0.80‒1.83) | 0.371 | 0.50 | (0.25‒1.21) | 0.081 | 0.81 | (0.40‒1.62) | 0.549 |
| No SA any diagnoses | 2.30 | (1.19‒4.43) | 0.013* | 2.57 | (1.63‒4.07) | < 0.0001*** | 0.46 | (0.21‒0.98) | 0.044* | 0.78 | (0.39‒1.55) | 0.475 |
| SA other diagnoses | 1.00 | (0.52‒1.93) | 0.993 | 1.32 | (0.86‒2.03) | 0.206 | 0.53 | (0.25‒1.15) | 0.108 | 0.84 | (0.42‒1.69) | 0.625 |
| No SA any diagnoses | 2.41 | (1.24‒4.67) | 0.009** | 2.96 | (1.83‒4.78) | < 0.0001*** | 0.45 | (0.21‒0.98) | 0.043* | 0.85 | (0.42‒1.70) | 0.643 |
| SA other diagnoses | 0.94 | (0.48‒1.82) | 0.856 | 1.26 | (0.83‒1.91) | 0.286 | 0.52 | (0.23‒1.16) | 0.108 | 0.95 | (0.46‒1.79) | 0.888 |
| No SA any diagnoses | 2.23 | (1.15‒4.33) | 0.017* | 2.60 | (1.64‒4.11) | < 0.0001*** | 0.44 | (0.20‒0.98) | 0.043* | 0.86 | (0.42‒1.79) | 0.695 |
| SA other diagnoses | 0.90 | (0.46‒1.76) | 0.764 | 1.23 | (0.81‒1.87) | 0.331 | 0.50 | (0.23‒1.08) | 0.079 | 0.78 | (0.39‒1.57) | 0.491 |
| No SA any diagnoses | 2.33 | (1.18‒4.61) | 0.015* | 3.01 | (1.87‒4.85) | < 0.0001 | 0.49 | (0.23‒1.06) | 0.070 | 0.82 | (0.41‒1.64) | 0.570 |
| SA other diagnoses | 1.01 | (0.52‒1.95) | 0.976 | 1.24 | (0.82‒1.88) | 0.314 | 0.53 | (0.25‒1.14) | 0.106 | 0.81 | (0.41‒1.63) | 0.561 |
| No SA any diagnoses | 2.50 | (1.28‒4.84) | 0.007** | 2.75 | (1.73‒4.37) | < 0.0001*** | 0.46 | (0.21‒0.98) | 0.045* | 0.79 | (0.39‒1.57) | 0.495 |
| SA other diagnoses | 0.98 | (0.50‒1.92) | 0.949 | 1.25 | (0.81‒1.93) | 0.317 | 0.43 | (0.19‒0.98) | 0.046 | 0.76 | (0.35‒1.62) | 0.472 |
| No SA any diagnoses | 2.15 | (1.07‒4.35) | 0.032* | 2.82 | (1.72‒4.63) | < 0.0001*** | 0.41 | (0.18‒0.94) | 0.034 | 0.73 | (0.34‒1.56) | 0.419 |
| SA other diagnoses | 1.07 | (0.56‒2.06) | 0.834 | 1.29 | (0.85‒1.94) | 0.233 | 0.51 | (0.24‒1.09) | 0.081 | 0.80 | (0.40‒1.63) | 0.541 |
| No SA any diagnoses | 2.50 | (1.29‒4.79) | 0.006** | 2.67 | (1.69‒4.22) | < 0.0001*** | 0.44 | (0.20‒0.94) | 0.035 | 0.75 | (0.37‒1.51) | 0.421 |
| SA other diagnoses | 0.82 | (0.41‒1.66) | 0.583 | 1.09 | (0.77‒2.00) | 0.379 | 0.53 | (0.22‒1.29) | 0.164 | 0.97 | (0.43‒2.18) | 0.944 |
| No SA any diagnoses | 2.14 | (1.04‒4.43) | 0.040* | 3.21 | (1.87‒5.50) | < 0.0001*** | 0.46 | (0.19‒1.11) | 0.083 | 0.90 | (0.40‒0.01) | 0.794 |
SA, sickness absence; RRR, relative risk ratio; CI, confidence interval. *p < 0.05, **p < 0.01, ***p < 0.001.